title: [CLINIC-EXPERIMENTAL SUBSTANTIATION OF OZONOTHERAPY APPLICATION IN THE TREATMENT OF PURULENT CHOLANGITIS AND OBTURATION JAUNDICE].
abstract: Efficacy of the ozonotherapy application as an important component of complex treatment in purulent cholangitis (PCH) was studied. In choledocholithiasis (without infectioning of bile) ozonotherapy may be prescribed as additional component at complex treatment. In PCH ozonotherapy application have promoted the improvement of laboratory indices in 6.6 times, comparing with such, occurring after basic therapy.
authors.forename: T A
authors.initials: TA
authors.lastname: Allazov
authors.forename: E A
authors.initials: EA
authors.lastname: Aliyeva
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D021461:Animals, Outbred Strains; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001219:Aspartate Aminotransferases / Q000097:blood; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D001646:Bile / Q000187:drug effects / Q000382:microbiology; D001652:Bile Ducts / Q000187:drug effects / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D001663:Bilirubin / Q000097:blood; D002176:Candida albicans / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification; D002761:Cholangitis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D042883:Choledocholithiasis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D004285:Dogs; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D041781:Jaundice, Obstructive / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D010126:Ozone / Q000494:pharmacology*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification; D013492:Suppuration / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D010126:Ozone; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin